BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ishikane S, Takahashi-Yanaga F. The role of angiotensin II in cancer metastasis: Potential of renin-angiotensin system blockade as a treatment for cancer metastasis. Biochem Pharmacol 2018;151:96-103. [PMID: 29534876 DOI: 10.1016/j.bcp.2018.03.008] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
Number Citing Articles
1 Ziaja M, Urbanek KA, Kowalska K, Piastowska-Ciesielska AW. Angiotensin II and Angiotensin Receptors 1 and 2-Multifunctional System in Cells Biology, What Do We Know? Cells 2021;10:381. [PMID: 33673178 DOI: 10.3390/cells10020381] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
2 Dusart P, Hallström BM, Renné T, Odeberg J, Uhlén M, Butler LM. A Systems-Based Map of Human Brain Cell-Type Enriched Genes and Malignancy-Associated Endothelial Changes. Cell Rep 2019;29:1690-1706.e4. [PMID: 31693905 DOI: 10.1016/j.celrep.2019.09.088] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
3 Zhang X, Zhang Y, Wang Y, Wu J, Chen H, Zhao M, Peng S. Modifying ICCA with Trp-Phe-Phe to Enhance in vivo Activity and Form Nano-Medicine. Int J Nanomedicine 2020;15:465-81. [PMID: 32021191 DOI: 10.2147/IJN.S229856] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Sun M, Fang Y, Ma S, Gao X, Sun Y. The genetic polymorphisms of angiotensin converting enzyme insertion/deletion and glioma susceptibility: A meta-analysis. J Renin Angiotensin Aldosterone Syst 2020;21:1470320320963939. [PMID: 33045911 DOI: 10.1177/1470320320963939] [Reference Citation Analysis]
5 Feng LH, Sun HC, Zhu XD, Zhang SZ, Li XL, Li KS, Liu XF, Lei M, Li Y, Tang ZY. Irbesartan inhibits metastasis by interrupting the adherence of tumor cell to endothelial cell induced by angiotensin II in hepatocellular carcinoma. Ann Transl Med 2021;9:207. [PMID: 33708834 DOI: 10.21037/atm-20-5293] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
6 Kilmister EJ, Tan ST. Insights Into Vascular Anomalies, Cancer, and Fibroproliferative Conditions: The Role of Stem Cells and the Renin-Angiotensin System. Front Surg 2022;9:868187. [DOI: 10.3389/fsurg.2022.868187] [Reference Citation Analysis]
7 Roth IM, Wickremesekera AC, Wickremesekera SK, Davis PF, Tan ST. Therapeutic Targeting of Cancer Stem Cells via Modulation of the Renin-Angiotensin System. Front Oncol 2019;9:745. [PMID: 31440473 DOI: 10.3389/fonc.2019.00745] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
8 van Dam PA, Huizing M, Mestach G, Dierckxsens S, Tjalma W, Trinh XB, Papadimitriou K, Altintas S, Vermorken J, Vulsteke C, Janssens A, Berneman Z, Prenen H, Meuris L, Vanden Berghe W, Smits E, Peeters M. SARS-CoV-2 and cancer: Are they really partners in crime? Cancer Treat Rev 2020;89:102068. [PMID: 32731090 DOI: 10.1016/j.ctrv.2020.102068] [Cited by in Crossref: 32] [Cited by in F6Publishing: 21] [Article Influence: 16.0] [Reference Citation Analysis]
9 Wang Y, Xu H, Fu W, Lu Z, Guo M, Wu X, Sun M, Liu Y, Yu X, Sui D. 20(S)-Protopanaxadiol Inhibits Angiotensin II-Induced Epithelial- Mesenchymal Transition by Downregulating SIRT1. Front Pharmacol 2019;10:475. [PMID: 31133857 DOI: 10.3389/fphar.2019.00475] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
10 Mravec B, Tibensky M, Horvathova L. Stress and cancer. Part II: Therapeutic implications for oncology. Journal of Neuroimmunology 2020;346:577312. [DOI: 10.1016/j.jneuroim.2020.577312] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
11 Wang X, Chen X, Xu H, Zhou S, Zheng Y, Keller BB, Cai L. Emerging roles of microRNA-208a in cardiology and reverse cardio-oncology. Med Res Rev 2021;41:2172-94. [PMID: 33533026 DOI: 10.1002/med.21790] [Reference Citation Analysis]
12 Haimerl L, Strobach D, Mannell H, Stief CG, Buchner A, Karl A, Grimm T. Retrospective evaluation of the impact of non-oncologic chronic drug therapy on the survival in patients with bladder cancer. Int J Clin Pharm 2021. [PMID: 34724148 DOI: 10.1007/s11096-021-01343-x] [Reference Citation Analysis]
13 Gelosa P, Castiglioni L, Camera M, Sironi L. Repurposing of drugs approved for cardiovascular diseases: Opportunity or mirage? Biochem Pharmacol 2020;177:113895. [PMID: 32145263 DOI: 10.1016/j.bcp.2020.113895] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
14 Sionov RV. Leveling Up the Controversial Role of Neutrophils in Cancer: When the Complexity Becomes Entangled. Cells 2021;10:2486. [PMID: 34572138 DOI: 10.3390/cells10092486] [Reference Citation Analysis]
15 Bui AD, Helgeson SA, Guru PK, Sanghavi DK. Angiotensin II for the treatment of septic shock in a neutropenic patient with T-cell acute lymphoblastic leukaemia. BMJ Case Rep 2020;13:e233432. [PMID: 32595128 DOI: 10.1136/bcr-2019-233432] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Lappano R, Jacquot Y, Maggiolini M. GPCR Modulation in Breast Cancer. Int J Mol Sci 2018;19:E3840. [PMID: 30513833 DOI: 10.3390/ijms19123840] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
17 Rachow T, Schiffl H, Lang SM. Risk of lung cancer and renin-angiotensin blockade: a concise review. J Cancer Res Clin Oncol 2021;147:195-204. [PMID: 33231730 DOI: 10.1007/s00432-020-03445-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Almutlaq M, Alamro AA, Alamri HS, Alghamdi AA, Barhoumi T. The Effect of Local Renin Angiotensin System in the Common Types of Cancer. Front Endocrinol (Lausanne) 2021;12:736361. [PMID: 34539580 DOI: 10.3389/fendo.2021.736361] [Reference Citation Analysis]
19 Takiguchi T, Takahashi-Yanaga F, Ishikane S, Tetsuo F, Hosoda H, Arioka M, Kitazono T, Sasaguri T. Angiotensin II promotes primary tumor growth and metastasis formation of murine TNBC 4T1 cells through the fibroblasts around cancer cells. Eur J Pharmacol 2021;909:174415. [PMID: 34375673 DOI: 10.1016/j.ejphar.2021.174415] [Reference Citation Analysis]
20 Domińska K. Involvement of ACE2/Ang-(1-7)/MAS1 Axis in the Regulation of Ovarian Function in Mammals. Int J Mol Sci 2020;21:E4572. [PMID: 32604999 DOI: 10.3390/ijms21134572] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
21 Garcia-Garduño TC, Padilla-Gutierrez JR, Cambrón-Mora D, Valle Y. RAAS: A Convergent Player in Ischemic Heart Failure and Cancer. Int J Mol Sci 2021;22:7106. [PMID: 34281199 DOI: 10.3390/ijms22137106] [Reference Citation Analysis]
22 Domińska K, Kowalska K, Habrowska-Górczyńska DE, Urbanek KA, Ochędalski T, Piastowska-Ciesielska AW. The opposite effects of angiotensin 1-9 and angiotensin 3-7 in prostate epithelial cells. Biochem Biophys Res Commun 2019;519:868-73. [PMID: 31563322 DOI: 10.1016/j.bbrc.2019.09.079] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
23 Lin YT, Wang HC, Tsai MH, Su YY, Yang MY, Chien CY. Angiotensin II receptor blockers valsartan and losartan improve survival rate clinically and suppress tumor growth via apoptosis related to PI3K/AKT signaling in nasopharyngeal carcinoma. Cancer 2021;127:1606-19. [PMID: 33405241 DOI: 10.1002/cncr.33391] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
24 Tabatabai E, Khazaei M, Asgharzadeh F, Nazari SE, Shakour N, Fiuji H, Ziaeemehr A, Mostafapour A, Parizadeh MR, Nouri M, Hassanian SM, Hadizadeh F, Ferns GA, Rahmati M, Rahmani F, Avan A. Inhibition of angiotensin II type 1 receptor by candesartan reduces tumor growth and ameliorates fibrosis in colorectal cancer. EXCLI J 2021;20:863-78. [PMID: 34121975 DOI: 10.17179/excli2021-3421] [Reference Citation Analysis]
25 Khoshghamat N, Jafari N, Toloue-Pouya V, Azami S, Mirnourbakhsh SH, Khazaei M, Ferns GA, Rajabian M, Avan A. The therapeutic potential of renin-angiotensin system inhibitors in the treatment of pancreatic cancer. Life Sci 2021;270:119118. [PMID: 33548284 DOI: 10.1016/j.lfs.2021.119118] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Feng LH, Sun HC, Zhu XD, Zhang SZ, Li KS, Li XL, Li Y, Tang ZY. Renin-angiotensin inhibitors were associated with improving outcomes of hepatocellular carcinoma with primary hypertension after hepatectomy. Ann Transl Med 2019;7:739. [PMID: 32042755 DOI: 10.21037/atm.2019.11.131] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
27 Fu C, Shi J, Su X, Feng S, Wang S. Ultrasound-stimulated microbubbles contributes to radiotherapy in esophageal carcinoma. Biochem Cell Biol 2021;99:707-16. [PMID: 34723651 DOI: 10.1139/bcb-2021-0061] [Reference Citation Analysis]